164 related articles for article (PubMed ID: 16278268)
1. A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency.
Murray RD; Adams JE; Shalet SM
J Clin Endocrinol Metab; 2006 Feb; 91(2):432-8. PubMed ID: 16278268
[TBL] [Abstract][Full Text] [Related]
2. Adults with partial growth hormone deficiency have an adverse body composition.
Murray RD; Adams JE; Shalet SM
J Clin Endocrinol Metab; 2004 Apr; 89(4):1586-91. PubMed ID: 15070916
[TBL] [Abstract][Full Text] [Related]
3. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
[TBL] [Abstract][Full Text] [Related]
4. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and bone health.
Bex M; Bouillon R
Horm Res; 2003; 60 Suppl 3():80-6. PubMed ID: 14671403
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
7. Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly.
Murray RD; Columb B; Adams JE; Shalet SM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1124-30. PubMed ID: 15001597
[TBL] [Abstract][Full Text] [Related]
8. Impact of growth hormone status on body composition and the skeleton.
Mukherjee A; Murray RD; Shalet SM
Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
[TBL] [Abstract][Full Text] [Related]
9. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
10. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
Ward KA; Roberts SA; Adams JE; Mughal MZ
Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis.
Murray RD; Bidlingmaier M; Strasburger CJ; Shalet SM
J Clin Endocrinol Metab; 2007 May; 92(5):1705-9. PubMed ID: 17327383
[TBL] [Abstract][Full Text] [Related]
12. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency.
Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):182-8. PubMed ID: 15670194
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
Baroncelli GI; Bertelloni S; Sodini F; Saggese G
Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
[TBL] [Abstract][Full Text] [Related]
15. Geometry and bone mass in primary hyperparathyroidism assessed by peripheral Quantitative Computed Tomography (pQCT).
Di Leo C; Bestetti A; Bastagli A; De Pasquale L; Tagliabue L; Bagni B; Pepe L; Tarolo GL
Radiol Med; 2003 Mar; 105(3):171-9. PubMed ID: 12835640
[TBL] [Abstract][Full Text] [Related]
16. The Impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency.
Maheshwari HG; Bouillon R; Nijs J; Oganov VS; Bakulin AV; Baumann G
J Clin Endocrinol Metab; 2003 Jun; 88(6):2614-8. PubMed ID: 12788864
[TBL] [Abstract][Full Text] [Related]
17. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
18. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
